Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association

firstwordpharmaFebruary 24, 2019

Tag: DBV Technologies , Viaskin Peanut , Novel Treatment

PharmaSources Customer Service